Novel administration of thrombopoietin

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/19 (2006.01) A61K 35/14 (2006.01)

Patent

CA 2288964

Thrombopoietin materials can be administered with substantial therapeutic effect in a single or low-multiple daily administration. Reversal of thrombocytopenia is achieved by administering to a patient having or in need of such treatment a single or low-multiple daily dose of a therapeutically effective amount of a thrombopoietin.

L'invention concerne des matières de thrombopoïétine pouvant être administrées de façon à obtenir un effet sensiblement thérapeutique en une seule prise quotidienne ou en plusieurs prises à faible dose. On obtient une inversion de la thrombocytopénie en administrant à un patient atteint de cette maladie ou nécessitant un tel traitement une seule dose quotidienne ou de multiples faibles doses d'une quantité thérapeutiquement efficace d'une thrombopoïétine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel administration of thrombopoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel administration of thrombopoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel administration of thrombopoietin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1371761

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.